Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107764 · ClinicalTrials.gov registry record · NA
Cerebellar Modulation of Cognition in Psychosis
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by Mclean Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 2
- Study locations
NCT06107764 is a NA study of Schizophrenia and Schizoaffective Disorder that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 95 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06107764, a NA study of Schizophrenia and Schizoaffective Disorder, is actively recruiting participants, sponsored by Mclean Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to learn about cognition in psychotic disorders (schizophrenia, bipolar disorder, and schizoaffective disorder). The main question it aims to answer is: Can we use magnetic stimulation to change processing speed (how quickly people can solve challenging tasks). Participants will be asked to perform cognitive tasks (problem-solving) and undergo brain scans before and after transcranial magnetic stimulation (TMS). TMS is a way to non-invasively change brain activity. Forms of TMS are FDA-approved to treat depression and obsessive compulsive disorder. In this study, we will use a different form of TMS to temporarily change brain activity to observe how that changes speed in problem-solving.
Conditions Studied
Interventions
- DEVICE sham rTMS
- DEVICE intermittant theta burst stimulation (iTBS)
- DEVICE continuous theta burst stimulation (cTBS)
Study Locations (2)
Massachusetts
- McLean Hospital - Belmont
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2024-07-31 |
| Est. Completion | 2029-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06107764
The ClinicalTrials.gov registry entry for NCT06107764 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (57% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which sham rTMS is the first listed.
NCT06107764 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06107764 about?
NCT06107764 is a clinical study titled "Cerebellar Modulation of Cognition in Psychosis". The goal of this clinical trial is to learn about cognition in psychotic disorders (schizophrenia, bipolar disorder, and schizoaffective disorder). The main question it aims to answer is: Can we use magnetic stimulation to change processing speed (how quickly people can solve challenging tasks). Pa...
What is the current status of trial NCT06107764?
This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2024-07-31. Estimated completion is 2029-12.
What conditions does trial NCT06107764 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder, Psychosis, Bipolar Disorder I.
What interventions are being tested in trial NCT06107764?
The interventions under investigation include: sham rTMS (DEVICE), intermittant theta burst stimulation (iTBS) (DEVICE), continuous theta burst stimulation (cTBS) (DEVICE).
Who is sponsoring clinical trial NCT06107764?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107764 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.